Expert Directory

counterfeit alcohol, Methanol Alcohol, Tainted Alcohol, Illicit Alcohol, Fake Alcohol, adulterated alcohol, illicit liquor, Methanol poisoning, Bootleg liquor, Counterfeit Liquor, tainted liquor, Drink Safe, Alcohol Poisoning


Joel C. Cantor, ScD

Director, Center for State Health Policy Distinguished Professor, Edward J. Bloustein School of Planning and Public Policy

Institute for Health, Health Care Policy and Aging Research at Rutgers University

Health Care Policy, Health Insurance Markets, Affordable Care Act , Medicaid, Homelessness and Health Care

Joel C. Cantor (Sc.D., Johns Hopkins University) is a Distinguished Professor of Public Policy and the Founding Director of the Center for State Health Policy at Rutgers University in New Brunswick, New Jersey. Established in 1999, the Center is a leader in health policy research and development nationally, with a special focus on informing policy in New Jersey. Dr. Cantor is published widely in the health services and policy literature on innovations in health service delivery and the regulation of private health insurance markets. He serves frequently as an advisor on health policy matters to New Jersey state government, and was the 2006 recipient of the Rutgers University President’s Award for Research in Service to New Jersey. In June 2017, Dr. Cantor was appointed Interim Director of the Rutgers Institute for Health, Health Care Policy and Aging Research. The Institute is the parent unit of the Center for State Health Policy and other centers and programs addressing critical health and mental health issues. Prior to joining Rutgers in 1999, Dr. Cantor served as director of research at the United Hospital Fund of New York and director of evaluation research at the Robert Wood Johnson Foundation. He received his doctorate in health policy and management from the Johns Hopkins University, School of Public Health in 1988, and was elected a Fellow of AcademyHealth in 1996.

Hot cars, Water Safety, Drowning, distracted driving, Holiday toy safety

Beaches, lakes, and pools are great ways to beat the heat but there are precautions to take before reaching for that swimsuit, said Gabriella Cardone, MD, an emergency medicine pediatrician with McGovern Medical School at UTHealth and attending physician at Children’s Memorial Hermann Hospital. “Taking the time to follow some basic precautions will keep you and your loved ones safe in the water all summer long,” Cardone said. Before engaging in aquatic activities, make sure everyone knows how to swim or has an approved life jacket. Water noodles, inner tubes, or water wings do not count. Tragically, there are approximately 3,536 fatal unintentional drownings in the U.S. every year, which is an average of 10 deaths a day, according to the Centers for Disease Control and Prevention. “Children should learn how to swim by age 4 and their parents should learn cardiopulmonary resuscitation or CPR in case of emergency,” Cardone said.

Olveen Carrasquillo, MD, MPH

Chief of the Division of General Internal Medicine and Public Health Disparity Expert

University of Miami Health System, Miller School of Medicine

Internal Medicine, Public Health, public health disparity

Dr. Carrasquillo is national expert in minority health, health disparities, community based participatory research, access to care and community health worker interventions. He has over twenty years of experience leading large NIH Center grants and randomized trials, totaling over $40 million in funding. His work includes research in cancer, diabetes, cardio-vascular disease, HIV, and most recently in precision medicine.

Dr. Carrasquillo is a Professor of Medicine and Public Health Sciences at the University of Miami’s Miller School of Medicine.  He is a Puerto Rican born physician who was raised in the Bronx.  He graduated summa cum laude from the Sophie Davis School of Bio-Medical Education at City College and obtained his MD degree from the New York University School of Medicine.  He completed a three-year internal medicine residency at Columbia-Presbyterian Medical Center, Harvard’s two-year General Medicine Fellowship and an MPH from the Harvard School of Public Health.  Prior to UM, Dr. Carrasquillo was Director of the Center of Excellence in Health Disparities Research at Columbia University.

For the last nine years, he has been the Chief of the Division of General Internal Medicine.  He oversees a clinical, teaching and research enterprise of 44 full-time faculty including six primary care practices and an additional ambulatory hospital-based clinic at Jackson Health System (Miami Public Hospital system).  Dr. Carrasquillo is a national expert in minority health, health disparities, community-based participatory research, access to care and community health worker interventions.  He has over twenty years of experience leading large NIH Center grants and randomized trials, totaling over $60 million in funding.  His work includes research in diabetes, cardiovascular disease, HIV, cancer and most recently in precision medicine.  His research has been published in many of the nation’s top medical journals and he serves on numerous NIH grant review committees.  He is also active in various national organizations, including numerous current and past leadership roles in the Society of General Internal Medicine, Physicians for a National Health Program, National Hispanic Medical Association and Latinos for National Health Insurance.  In Miami, he is a Board Member of the Miami-Dade Area Health Education Center and the South Florida Health Council.  He is often called upon by the media to discuss his research as well as healthcare topics of particular relevance to the Hispanic community including being a frequent guest on most of the major Latinotelevision networks.

RNA Silencing, Virus-Host Interactions, Epigenetics

Jim Carrington has come a long way since first stepping into a research laboratory as an undergraduate at the University of California, Riverside.

Research in the Carrington lab focuses on RNA-mediated regulation and silencing of genomes, genes and viruses. This lab focuses on the biogenesis, functions, and evolution of small RNA-directed silencing pathways in multicellular eukaryotes. Small RNA-based silencing serves a regulatory mechanism during growth and development and in response to stress. It also functions as a transposon and repeat silencing mechanism, and as an antiviral response in plants and some animals. The Carrington lab uses a combination of genetics, genomics, computation and other approaches to address fundamental mechanistic problems using model systems, but it also seeks to develop tools and approaches that have practical relevance in crop plants. The lab is particularly interested in the underlying mechanisms, including small RNA mechanisms, that govern plant-virus and plant-microbe interactions.

HTS studies in a variety of plants and other organisms have revealed the diversity of ancient and recently evolved miRNA genes, and vast arrays of siRNAs from long dsRNA. The systematic analysis of mutants with defects in miRNA and siRNA function revealed several distinct biogenesis pathways for each class, and target RNAs that are regulated by small RNA families. Distinct small RNA biogenesis and effector components are involved in transcriptional and post-transcriptional silencing systems in plants. They have explored biogenesis, effector and specificity mechanisms of miRNA, trans-acting siRNA (tasiRNA), antiviral siRNA, and other small RNA classes using Arabidopsis thaliana.

Anees Chagpar, MD, MBA, MPH, FACS, FRCS(C)

Associate Professor; Director, Assistant Director

Yale Cancer Center

Breast Cancer, Yale Cancer Center, breast surgeon, hereditary breast and ovarian cancer syndrome breast cancer, Breast Neoplasms, Global affairs, Healthcare

Anees is the Director of The Breast Center, Smilow Cancer Hospital at Yale-New Haven, an Associate Professor in the Department of Surgery, Yale School of Medicine, and the Assistant Director for Global Oncology at Yale Comprehensive Cancer Center. Born and

Christine Chambers, PhD

Scientific Director of the CIHR Institute of Human Development, Child and Youth Health

Canadian Institutes of Health Research (CIHR)

Parents & Families, Implementation Science, knowledge translation, Health Psychology, pediatric pain

Dr. Christine Chambers is the Canada Research Chair (Tier 1) in Children’s Pain and a Killam Professor in the departments of Psychology & Neuroscience and Pediatrics at Dalhousie University in Halifax, Nova Scotia. She is also the Scientific Director of Solutions for Kids in Pain (SKIP), a national knowledge mobilization network funded by the Networks of Centres of Excellence and co-directed by Children’s Healthcare Canada. She is a member of the Royal Society of Canada’s College of New Scholars, Artists and Scientists. Dr. Chambers completed her PhD in Clinical Psychology at the University of British Columbia and her internship in the Brown University School of Medicine.

Dr. Chambers’ research lab is based in the Centre for Pediatric Pain Research at the IWK Health Centre. She was identified as one of the top 10 most productive women clinical psychology professors in Canada and has published over 150 peer-reviewed papers on the role of developmental, psychological, and social influences on children’s pain. Her expertise spans knowledge generation (e.g., original studies), synthesis (e.g., systematic review, guidelines), and translation (e.g., policy, public outreach).

Dr. Chambers was a Mayday Pain and Society Fellow. She has given a TEDx talk on children’s pain and developed a YouTube video for parents about how to manage needle pain (also available in French). She led the #ItDoesntHaveToHurt initiative, in partnership with Erica Ehm’s YummyMummyClub, funded by the Canadian Institutes of Health Research (CIHR). She is the Assistant Director of the North American Pain School and has played a key role in other training programs. Dr. Chambers has received numerous awards for her research, mentorship, patient engagement, and advocacy, including the Children’s Healthcare Canada Leadership Award (2017). Her research is regularly featured in the media, including The Globe and Mail, The New York Times, and the CBC.

Dr. Chambers is a past member of the Institute Advisory Board for the CIHR Institute of Musculoskeletal Health and Arthritis, a Section Editor for the European Journal of Pain, Associate Editor for PAIN and PAIN Reports, and a member of the editorial board for the Canadian Journal of Pain. She gives presentations for scientists, health professionals, parents, and patients around the world.

The Women’s Executive Network named Dr. Chambers one of the 2019 Canada’s Most Powerful Women: Top 100 Award Winners, joining a community of Canada’s most influential women leaders.

Jenny Chang, MD

Director, Houston Methodist Cancer Center

Houston Methodist


Chang's work focuses on the therapy resistance of cancer stem cells, which has led to several publications and international presentations. Her clinical research aims to evaluate novel biologic agents in breast cancer patients. Chang has worked in the field of tumor-initiating cells for more than 10 years. After her discovery that tumor-initiating cells are chemo-resistant, and that targeting the EGFR/HER2 pathway can decrease this subpopulation, Chang played a key role in demonstrating some of the limitations and mechanisms of tumor-initiating cells. Her work is now focused on the mechanisms that regulate TICs, as well as initiating and planning clinical trials that target this critical tumor initiating subpopulation. She is also interested in characterizing the cross-talk between these different pathways that may lead to mechanisms of resistance, and has identified some of the chief regulatory pathways involved in TIC self-renewal. She is a world-renown clinical investigator, credited as one of the first to describe intrinsic chemo-resistance of tumor-initiating cells.

Bernard W. Chang, MD

Director, Plastic & Reconstructive Surgery at Mercy

Mercy Medical Center

Plastic Surgery, Reconstructive Surgery, Surgery, Breast Reconstruction Surgery, Cosmetic Surgery

Bernard (Bernie) W. Chang, M.D., Director of Baltimore’s Plastic & Reconstructive Surgery at Mercy, also leads The Breast Reconstruction and Restoration Center at Mercy. Dr. Bernie Chang is Board Certified in Plastic Surgery and General Surgery. He pioneered and advanced surgical treatment options like DIEP flap surgery for breast reconstruction. With a skilled and highly specialized team of doctors, Mercy's Plastic Surgery and Breast Reconstruction Centers are known as one of the Mid-Atlantic’s best in breast reconstruction and restoration, cosmetic medicine and plastic surgery. 

As the Assistant Director of The Hoffberger Breast Center at Mercy in Baltimore, Dr. Bernie Chang works closely with the Breast Center doctors to provide seamless care for those women who choose immediate breast reconstruction after breast surgery. The industry-leading expertise of Dr. Chang and the renowned reputation of the physicians of The Breast Center result in choices that women may not find elsewhere.

With more than 20 years of medical experience, Dr. Chang offers women peace of mind in breast reconstruction and restoration. His quiet thoughtfulness and attention to the needs of his patients provide a calming touch that helps each woman focus on her treatment options and recovery. His expertise is in helping women reclaim their feminine form and personal self-esteem after a diagnosis and treatment for breast cancer. Women say they have regained their physical and emotional balance in the care of Dr. Chang.

Dr. Chang has performed DIEP flap breast reconstruction surgery for decades and his leadership is widely known. DIEP flap breast reconstruction surgery is one of the most widely performed breast shaping options for women. Dr. Chang is also skilled in other microsurgical flap procedures including:

DIEP flap
SGAP flap & Bilateral SGAP Flap
IGAP flap
TUG flap
Latissimus flap
Dr. Bernie Chang’s surgical expertise attracts surgical fellows from across the nation to train in the renowned Fellowship Program at Mercy in breast reconstruction and surgical flap treatment options.

Michael L. Chang, MD

Assistant Professor Of Pediatrics Director Of Pediatric Antimicrobial Stewardship For McGovern Medical School And Children's Memorial Hermann Hospital

University of Texas Health Science Center at Houston

Process Improvement, Healthcare Quality, Patient Safety

Dr. Michael L. Chang is a pediatric infectious disease specialist in Houston, Texas, and is affiliated with multiple hospitals in the area. He has been in practice for 11-20 years. His specialty is Pediatric infectious disease specialists who treat children with a broad array of diseases caused by germs, viruses, and fungi, ranging from flu to hospital-acquired infections to pneumonia.

Dr. Chang’s professional interests include Antimicrobial stewardship which involves studying and promoting the appropriate, optimal and judicious use of antibiotics for pediatric patients and Carbapenem-resistant Gram-negative bacterial infections.

Linda Charmaraman, PhD

Senior Research Scientist; Director, Youth, Media & Wellbeing Research Lab

Wellesley College, Wellesley Centers for Women

teen social media use, youth development , Cyberbullying, Gaming, social media and anxiety, Social Media

Linda Charmaraman, Ph.D., is a senior research scientist at the Wellesley Centers for Women and project director of the Youth, Media & Wellbeing Research Lab. She conducts research funded by a 3-year National Institutes of Health grant to follow middle school students and their parents longitudinally in order to determine longer-term health and wellbeing effects due to early smartphone use, social media use, and gaming. One of the goals of her project is not only to prevent negative health effects of social media use but also to empower youth to use social media to increase connections with other people by giving and receiving social and emotional support through social media and finding ways to be more civically engaged.

Charmaraman has conducted research and evaluation on projects funded by the National Institutes of Health, Department of Education, the Centers for Disease Control and Prevention, William T. Grant Foundation, Planned Parenthood League of Massachusetts, Kellogg Foundation, Schott Foundation for Public Education, United Way, Borghesani Community Foundation, and AIDS Action Committee of Massachusetts.

Charmaraman was a Visiting Assistant Professor in Asian American Psychology at Wellesley College and has guest lectured at Boston College and Northeastern University. Mentoring undergraduate and graduate students has always been a passion of hers, evidenced by her dedication to training, collaborating, presenting, and publishing academic papers with students from multiple institutions. Throughout her doctoral program, she was the coordinator of graduate student diversity recruitment in her department and an appointed student delegate of the Equity Committee.

Jennifer A. Chatman, PhD

Paul J. Cortese Distinguished Professor of Management

University of California, Berkeley Haas School of Business

Organizational Culture, Firm Performance, Norms in Diverse Groups, Leadership and the Impact of Leader Attributes, Organizational Management

Jennifer Chatman is a world-renowned researcher, teacher & consultant on leveraging organizational culture for firm performance and leading high-performance teams.

Chatman is the Paul J. Cortese Distinguished Professor of Management and a faculty member in the Management of Organizations (MORS) Group at Berkeley Haas. In her research, teaching, and consulting work, she focuses on how organizations can leverage culture for strategic success and how diverse teams can optimize performance. Her award-winning research has shown, for example, how emphasizing innovation in the context of a strong culture increases firms’ financial success, how narcissistic leaders create organizational cultures lower in collaboration and integrity, and how norms to cooperate can cause members to blur differences among them, even if those differences are useful for group performance—suggesting that collaboration should be calibrated in diverse teams.

Chatman is the Co-Director of the Berkeley Culture Initiative, the Assistant Dean for Learning Strategies at the Haas School of Business, an Editor for the journal Research in Organizational Behavior, and runs the Leading High Performance Cultures executive education program. She has served in many other leadership roles at Haas and UC Berkeley over the years. Chatman earned her PhD at Berkeley Haas, and her BA in Psychology from UC Berkeley.

Lauren Chenarides, PhD

Assistant Professor, Morrison School of Agribusiness in the W. P. Carey School of Business

Arizona State University (ASU)

Food Marketing, Food Retail, consumer demand, Food decision-making

Lauren Chenarides is an expert in food policy and marketing, data analysis, and consumer demand.
Her research focuses on understanding the barriers people face to access affordable, healthy foods and the consequences of poor food access.

Additionally, she examines how food retailers’ decisions might exacerbate or mitigate the hardships consumers face living in underserved areas. 

Lauren Chenarides is an assistant professor at the Morrison School of Agribusiness in the W. P. Carey School of Business.

Professor Chenarides is actively involved in scholarly associations, including the Agricultural and Applied Economics Association, American Economic Association, and Northeast Agricultural and Resource Economics Association.

Mohamad Cherry, MD

Medical Director, Hematology, Atlantic Health System Cancer Care

Atlantic Health System

Hematology, Medical Oncology, Clinical Trials, hematologic malignancies, new therapeutics for relapsed and refractory blood cancers, Epigenetics

Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System Cancer Care. He joined Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.

With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.

Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.

As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.

Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits.

Henry Chesbrough, PhD

Faculty Director, Garwood Center for Corporate Innovation | Adjunct Professor | Mike and Carol Meyer Fellow

University of California, Berkeley Haas School of Business

technology management, Innovation Strategy, Corporate Innovation, Open Innovation, Business Development, Managing Intellectual Property, Industry Evolution

Henry Chesbrough, who coined the term “open innovation,” is faculty director of the Garwood Center for Corporate Innovation at Berkeley Haas. His research focuses on technology management and innovation strategy. He also teaches at Esade Business School at Spain’s University Ramon Llull. He has been an adjunct professor at the Harvard Business School and previously served as product manager and vice president of marketing at Quantum Corporation, a manufacturer of data storage devices and systems. He earned a BA in economics from Yale University, an MBA from Stanford University, and a PhD in business administration from Berkeley Haas.

Open innovation is a paradigm that assumes that firms can and should use external and internal ideas and paths to market to advance their technology. The central idea behind open innovation is that—in a world of widely distributed knowledge where the boundaries between a firm and its environment have become more permeable—companies cannot afford to rely entirely on their own research but should instead buy or license processes or inventions from other companies. In addition, internal inventions not being used in a firm’s business should be taken outside the company (e.g., through licensing, joint ventures, spin-offs).

Asian American, Pacific Islanders

Christina Chin is anticipating the Aug. 15 opening of the romantic comedy “Crazy Rich Asians” and the insights the film offers into the Asian American second-generation experience.

The film, based on the book of the same name by Kevin Kwan, is the first from a major Hollywood studio to feature an entirely Asian cast in a present-day story since the release 25 years ago of “The Joy Luck Club.” 

Chin, who has previewed the film, notes that the story it tells goes beyond money and wealth to highlight universal themes about love, friendship and negotiating family dynamics “that transcend ethnic and racial boundaries.”

The assistant professor of sociology is co-author of a widely reported 2017 study “Tokens on the Small Screen” about how Asian Americans and Pacific Islanders remain underrepresented on television. She and scholars from five other universities collaborated on the study, a 10-year follow-up to and expansion of an earlier study of Asian Americans and Pacific Islanders on prime-time series television.

Chin’s teaching and scholarly research interests include immigration, racial and ethnic identity, youth and popular culture. Chin is co-editor of "Asian American Sporting Cultures" (NYU Press -2016).  Chin earned her doctorate at UCLA. Prior to joining the Cal State Fullerton faculty, she was a postdoctoral fellow for the Asian American Studies Department at the University of Illinois, Urbana-Champaign.

Prescription Drug Cost, video game industry, Banking, behavior analysis, peer-to-peer, Lending, Economics, Marketing, Management Science, Nursing Home, Econometrics

Andrew Ching is a professor in the Carey Business School at the Johns Hopkins University, where he is jointly appointed to the Department of Economics and the Bloomberg School of Public Health.  He is currently serving as an Associate Editor for Management Science, and a member of editorial boards for Marketing Science and Journal of Marketing Research.  His research focuses on developing new empirical structural models and estimation methods to understand the forward-looking, strategic, learning and bounded rational behavior of consumers and firms.  He has applied these methods to several industries including prescription drugs, nursing homes, payment methods, retail banking, peer-to-peer lending, and video games. He has published in Econometrica, Mangement Science, Marketing Science, Journal of Banking and Finance, Journal of Applied Econometrics, and others. He has received Young Economist Award from the European Economic Association, Honorable Mention of Dick Wittink Prize Award, and several major research grants from Social Sciences and Humanities Research Council in Canada.

Large Data Analysis, Machine Learning for Robotics and Autonomy, Deep Learning

Professor Anna Choromanska did her Post-Doctoral studies in the Computer Science Department at Courant Institute of Mathematical Sciences in NYU and joined the Department of Electrical and Computer Engineering at NYU Tandon School of Engineering in Spring 2017 as an Assistant Professor. She is also affiliated with the NYU Center for Data Science, the NYU Center for Urban science and Progress (CUSP), and the NYU Center for Advanced Technology in Communications (CATT). Anna Choromanska is a recipient of the Alfred. P. Sloan Fellowship and IBM Faculty Award. 

Prof. Choromanska's research interests focus on machine learning both theoretical and applicable to the variety of real-life phenomena. Currently, her main research projects focus on optimization (deep learning landscape, deep learning optimization, and general machine learning optimization), large data analysis (extreme multi-class and multi-label classification and density estimation), and machine learning for robotics and autonomy (autonomous driving systems, self-driving cars, AI-based robotics). Prof. Choromanska collaborates with NVIDIA (New Jersey lab) on the autonomous car driving project. 

Prof. Choromanska was a recipient of The Fu Foundation School of Engineering and Applied Science Presidential Fellowship at Columbia University in the City of New York. She co-authored several international conference papers and refereed journal publications, as well as book chapters. The results her works are used in production by Facebook (training production vision systems and entry to COCO competition) and Baidu, and in product development by NVIDIA. She is also a contributor to the open source fast out-of-core learning system Vowpal Wabbit (aka VW). Prof. Choromanska gave over 50 invited and conference talks and serves as a book editor (MIT Press volume), organizer of top machine learning events (workshops at conferences such as the  International Conference on Neural Information Processing Systems), and a reviewer and area chair for several top machine learning conferences and journals.

Prof. Anna Choromanska is also a pianist who has been playing piano since the age of six and has diplomas of two music schools. Her piano performance can be found here. She was also a bronze medalist of amateur couple dance. She was practicing standard and latin dance in the Columbia University Ballroom Dance Team. Prof. Choromanska is also an avid salsa dancer. She performed in Ache Performance Project of Frankie Martinez, the one of the most innovative and renowned Latin contemporary dancers of his generation, and practiced individually with one of the most charismatic female mambo dancers, Lori Ana Perez-Piazza. She also likes dancing hula, especially during her travels to Hawaii. Her dance performances can be found here, here and here. Finally, prof. Choromanska loves painting and fashion design techniques. She comes from a scientific family: her father, Wlodzimierz Choromanski, was a professor of transportation and her mother, Danuta Jasińska-Choromańska, is a professor of mechatronics at the Warsaw University of Technology, Poland. 


Suicide, Ethnic Minority Populations, Diversity

Joyce Chu, Ph.D., is a Professor at Palo Alto University. She earned her B.A. and M.A. in psychology at Stanford University, her Ph.D. in clinical psychology from the University of Michigan, and did a postdoctoral fellowship at the University of California, San Francisco. Dr. Chu co-leads the Multicultural Suicide and Ethnic Minority Mental Health Research Groups at PAU, and is also Director of the Diversity and Community Mental Health (DCMH) emphasis which trains future psychologists to work with underserved populations in the public mental health sector. Under her leadership, the DCMH emphasis received awards for innovative practices in graduate education in psychology in 2011 by both the American Psychological Association Board of Educational Affairs, and the National Council of Schools and Programs of Professional Psychology. Dr. Chu also co-directs PAU’s Center for Excellence in Diversity, which was founded in 2010 by Dr. Stanley Sue. At PAU, she is an associated researcher with the Center for LGBTQ Evidence-based Applied Research Group.

Dr. Chu’s work is focused around depression and suicide in ethnic minority adult and geriatric populations, particularly in Asian Americans. Her work is community-collaborative and aims to understand barriers to service use and develop culturally congruent outreach and service options for Asian Americans and other underserved communities. She has an interest in advancing the assessment and prevention of suicide for cultural minority populations, and has published a cultural theory and model of suicide with her collaborators Peter Goldblum and Bruce Bongar. As part of this work, she and her colleagues have developed a tool to assist clinicians in accounting for cultural influences on suicide risk.

In 2012, Dr. Chu received the APA Division 12 Samuel M. Turner Early Career Award for Distinguished Contributions to Diversity in Clinical Psychology. In 2013, she was awarded the AAPA Early Career Award from the Asian American Psychological Association (AAPA).

Christine Chung, JD

Gov. George E. Pataki Distinguished Professor of Law

Albany Law School

Business, Contracts, Financial Crimes, Market Regulation, Corporate law, Securities Law and Litigation, White Collar Crime

Professor of Law Christine Chung draws upon her deep knowledge of and experience with financial markets, corporate governance norms, complex business transactions, and government investigations to examine financial market regulatory systems, capital markets and corporate and securities law systems, municipal finance, and consumer and investor protection. Professor Chung's teaching and research interests include regulatory architecture and regulatory reform, risk management (including systemic risk management), compliance, corporate governance, investor protection and feminist jurisprudence. She frequently presents on issues associated with securities fraud and investor protection, the recent financial crisis, and municipal financial distress.

Prior to joining Albany Law School, Professor Chung served as a partner at Goodwin Procter LLP, where she was a member of the firm's securities and white collar crime practice groups. While at Goodwin, Professor Chung specialized in complex business litigation and civil and criminal securities-related enforcement matters, including proceedings involving the Department of Justice, the United States Securities and Exchange Commission, the National Association of Securities Dealers (now known as FINRA) and various state attorneys general. She also specialized in compliance and risk management counseling for clients. Her clients included mutual funds, investment advisors, broker-dealers, bank holding companies, complex operating companies, officers, directors and employees.

Before joining Goodwin Procter, Professor Chung served as Branch Chief of the Enforcement Division of the United States Securities and Exchange Commission, among other posts. As a member of the Enforcement Division, Professor Chung specialized in investigating and litigating cases involving a wide range of alleged securities-related misconduct, including matters involving alleged financial reporting fraud, insider trading, and professional misconduct by accounting professionals.

Professor Chung is co-director of the joint Albany Law School/UAlbany Institute for Financial Market Regulation. Professor Chung initially joined Albany Law's faculty in 2007 as director of the Securities Arbitration Clinic.